News|Articles|July 30, 2024
Hydrophobic Interaction Chromatography: A Platform for Characterizing Antibody-Drug Conjugates
Author(s)Tosoh Bioscience
Characterizing the ratio of tumor-killing payload to cancer-binding antibody (DAR) is a critical quality attribute that helps determine the potential potency of a given antibody-drug conjugate (ADC) candidate. The TSKgel® HIC-ADC Butyl column, developed by Tosoh Bioscience, enables improved HIC-based separations for quantifying the DAR of ADCs.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Trending on LCGC International
1
HPLC 2025 Revisited: A Year-End Review of LCGC's Conference Coverage Highlights (Part One)
2
A Novel Machine Learning Method for Predicting Retention Time of Small Molecule Pharmaceutical Compounds Across Reversed-phase HPLC Columns
3
Dr. Rigoberto Advincula on Advancing Polymer Research With Py-GC/MS
4
Best of the Week: Career Opportunities for PhD Graduates, Human Expertise and Machine Learning
5